Global Milbemycin Oxime API Supply, Demand and Key Producers, 2023-2029

Global Milbemycin Oxime API Supply, Demand and Key Producers, 2023-2029

The global Milbemycin Oxime API market size is expected to reach $ 286.7 million by 2029, rising at a market growth of 6.1% CAGR during the forecast period (2023-2029).

Global 3 largest manufacturers of Milbemycin Oxime API are Livzon Pharmaceutical Group Inc, Zhejiang Hisun Pharmaceutical Co., Ltd and Hubei Honch Pharmaceutical Co.,Ltd, which make up over 40%. Among them, Livzon Pharmaceutical Group Inc is the leader with about 22% market share. North America is the largest market, with a share about 48%, followed by Europe and China, with the share about 46% and 2%. In terms of product type, Purity Greater than 98% occupy the largest share of the total market, about 85%. And in terms of product Application, the largest application is Dog, followed by Cat.

Milbemycin is a new type of semi-synthetic macrolide anthelmintic. It is an oxime derivative of Milbemycin A3 and A4. The molecular weight of A3 oxime is 541.7, and the molecular weight of A4 oxime is 555.7. In terms of application, milbexime can be used alone or in combination with nitenpyram, lufenuron, spinosad, praziquantel, etc. to form a compound preparation, which can effectively prevent and control heartworms, hookworms, roundworms, whipworms, roundworms and other internal parasites, as well as hair follicles, scabies, lice, fleas and other external parasites. Milbexime acts as an agonist of the GABA (gamma-aminobutyric acid) neurotransmitter in nerve cells and also binds to glutamate-gated Cl– channels in invertebrate nerve and muscle cells. In both cases, it blocks the parasite's nerve signaling, eventually paralyzing the parasite, causing the muscles to lose their ability to contract, stop feeding, and cause the parasite to die.

This report studies the global Milbemycin Oxime API production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Milbemycin Oxime API, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Milbemycin Oxime API that contribute to its increasing demand across many markets.

Highlights and key features of the study

Global Milbemycin Oxime API total production and demand, 2018-2029, (KG)

Global Milbemycin Oxime API total production value, 2018-2029, (USD Million)

Global Milbemycin Oxime API production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (KG)

Global Milbemycin Oxime API consumption by region & country, CAGR, 2018-2029 & (KG)

U.S. VS China: Milbemycin Oxime API domestic production, consumption, key domestic manufacturers and share

Global Milbemycin Oxime API production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (KG)

Global Milbemycin Oxime API production by Type, production, value, CAGR, 2018-2029, (USD Million) & (KG)

Global Milbemycin Oxime API production by Application production, value, CAGR, 2018-2029, (USD Million) & (KG).

This reports profiles key players in the global Milbemycin Oxime API market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Livzon Pharmaceutical Group Inc, Zhejiang Hisun Pharmaceutical Co., Ltd, Hubei Honch Pharmaceutical Co.,Ltd and JIANGSU LINGYUN PHARMACEUTICAL CO.，LTD, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Milbemycin Oxime API market.

Detailed Segmentation:

Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (KG) and average price (US$/KG) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Milbemycin Oxime API Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global Milbemycin Oxime API Market, Segmentation by Type
98% Purity
Purity Greater than 98%

Global Milbemycin Oxime API Market, Segmentation by Application
Dog
Cat
Other

Companies Profiled:
Livzon Pharmaceutical Group Inc
Zhejiang Hisun Pharmaceutical Co., Ltd
Hubei Honch Pharmaceutical Co.,Ltd
JIANGSU LINGYUN PHARMACEUTICAL CO.，LTD

Key Questions Answered

1. How big is the global Milbemycin Oxime API market?

2. What is the demand of the global Milbemycin Oxime API market?

3. What is the year over year growth of the global Milbemycin Oxime API market?

4. What is the production and production value of the global Milbemycin Oxime API market?

5. Who are the key producers in the global Milbemycin Oxime API market?

6. What are the growth factors driving the market demand?